You got your blood test back. Glucose: normal. HbA1c: fine. Doctor says you’re all clear. But you’re gaining weight around your middle, your energy crashes after lunch, and something just feels off. Here’s what the standard panel almost certainly missed — and the silent cascade it’s allowing to run unchecked inside your body right now.
That disconnect between how your results look on paper and how you actually feel is not in your head. It reflects a genuine blind spot in the way routine blood work is designed. Standard panels were built to catch disease once it has arrived — elevated glucose, diagnosable diabetes. They were not built to catch the decade-long process that precedes it. And that process has a name, a measurable biomarker, and a clear biological sequence. You just weren’t tested for it.
The Test Your Doctor Probably Didn’t Order — And Why It Matters
What fasting insulin actually measures (and what glucose cannot tell you alone)
Think of your body’s blood sugar system like a nightclub with a strict door policy. Insulin is the bouncer — its job is to let glucose into your cells. In the early stages of what researchers call insulin resistance, the cells stop responding to the bouncer. So the pancreas hires more bouncers, flooding your bloodstream with extra insulin to force the doors open. From the outside — meaning your glucose reading — everything looks orderly. The queue is moving. But inside, the club is dangerously overcrowded, the manager (your liver) is overwhelmed, the fire exits (fat metabolism) are blocked, and the whole building is one spark away from a serious incident.
Fasting insulin is the test that counts how many bouncers are working. Under normal conditions, the pancreas runs at near-minimal insulin output during a fasted state — beta cells are largely quiet when you haven’t eaten. A high fasting insulin reading therefore tells you one thing with precision: the system is working overtime just to keep glucose normal. The glucose number looks fine because the insulin is compensating. But the compensation itself is the problem.
The compensation trap: how your pancreas hides the problem for years
This is the cruelest feature of early insulin resistance. The very mechanism your body uses to manage it — producing more insulin — is what makes it invisible to standard testing. Your fasting glucose stays in range. Your HbA1c, which measures your average blood sugar control over roughly three months (the technical term is glycated haemoglobin), remains unremarkable. And so your doctor, working from the tools available in a standard panel, tells you everything is fine.
Meanwhile, in people with insulin resistance, the normal suppression of insulin during fasting is impaired — insulin stays elevated when it should be low. That elevated number is the earliest measurable upstream signal of a cascade that, left undetected, quietly reshapes your metabolism over years. The challenge is that this is exactly the kind of question a routine annual check-up was not designed to answer — not because doctors don’t care, but because population-level reference ranges were never built to account for your specific risk profile, and fasting insulin is simply not part of the standard order set in most primary care settings.
Step 1 of the Cascade — Insulin Resistance Takes Root
How chronic energy surplus breaks the nutrient storage system
Insulin resistance doesn’t arrive suddenly. It develops through a slow erosion of the body’s ability to manage fuel. The nutrient storage pathways that give rise to insulin resistance were evolved to maximise efficient energy use during feast-and-famine cycles — not to handle the relentless caloric availability of modern life. Your cells are running software written for scarcity. The environment is providing abundance. Eventually, the system starts to reject the signal.
When cells are repeatedly exposed to high insulin levels — because you’re eating frequently, because portions have expanded, because processed carbohydrates spike glucose faster than the body’s systems were designed to handle — the cellular machinery that responds to insulin begins to downregulate. It’s a protective adaptation. But it creates a vicious loop: less cellular response means the pancreas produces even more insulin to compensate, which drives further desensitisation.
What changes in your cells before any standard test flags a problem
Inside the muscle and fat cells, the pathway through which insulin normally signals glucose uptake — a chain of molecular switches collectively called the insulin signalling cascade — begins to malfunction at specific points. The surface receptors that detect insulin are still present. But the downstream communication breaks down. The doors exist. The bouncer is there. The door simply doesn’t open when he knocks. None of this shows up as elevated glucose — not yet. The pancreas is still compensating. But the cellular architecture has already shifted.
Step 2 of the Cascade — The Liver Gets Hijacked
How a resistant liver starts overproducing both glucose and fat
Once insulin resistance takes root in peripheral tissues, it eventually reaches the liver — and this is where the cascade accelerates. Under normal conditions, insulin performs three coordinated jobs in the liver: it promotes the storage of glucose as glycogen (the liver’s short-term fuel reserve), it increases the expression of genes that produce fat, and critically, it suppresses the liver’s own glucose output. When insulin signalling becomes impaired in the liver, all three of these controls fail simultaneously — driving both rising blood glucose and a worsening lipid profile at the same time.
This is a crucial point. The liver is not malfunctioning randomly. It’s responding logically to a broken signal. With insulin resistance, the suppression mechanism fails, and the liver keeps producing glucose even when blood sugar is already adequate. It also begins overproducing fat particles — specifically a type of fat-carrying particle called very-low-density lipoprotein (VLDL) — which is how a metabolic problem that starts in one tissue starts showing up in your blood panels as a lipid problem.
Why your triglycerides and LDL particle pattern shift even when your glucose looks fine
The excess fat the liver is now manufacturing gets exported into the bloodstream as triglycerides — a type of blood fat that most standard panels do measure, though its connection to insulin resistance is rarely explained. Elevated triglycerides suppress the production of large, buoyant HDL particles (the so-called “good cholesterol”) and simultaneously cause a shift in LDL particles toward smaller, denser variants that are more damaging to artery walls. Your total LDL number may look acceptable on paper. But the particle composition has changed in a direction that significantly increases cardiovascular risk — and that change was driven by insulin, not glucose. Insulin regulates lipid metabolism directly through the insulin signalling cascade, creating a bidirectional loop where fat accumulation worsens insulin resistance and insulin resistance drives further fat production.
Step 3 of the Cascade — The Body-Wide Chain Reaction
Blood pressure, inflammation, and uric acid: why they rise together
What starts as a cellular signalling problem in muscle and liver does not stay contained. The metabolic consequences of insulin resistance extend to chronically elevated blood sugar, high blood pressure, worsening lipid profiles, elevated uric acid, and elevated inflammatory markers — a cluster that emerges not as five independent conditions but as downstream expressions of a single upstream problem. High insulin promotes sodium retention in the kidneys, which drives blood pressure up. It stimulates the sympathetic nervous system, keeping the body in a low-grade state of physiological alertness. It promotes a persistent, low-level activation of the immune system — what researchers call chronic low-grade inflammation — that gradually damages blood vessel walls and tissues across the body.
Uric acid, the same compound that causes gout, rises in parallel because the same metabolic pathways that become dysregulated in insulin resistance also impair the kidney’s ability to excrete uric acid efficiently. These aren’t coincidental associations. They share a common root.
Visceral fat as both product and fuel of the cascade
Fat stored around your organs — visceral fat, as opposed to the subcutaneous fat you can pinch under the skin — is not metabolically inert. It is biologically active tissue that secretes its own signalling molecules. As insulin resistance drives more fat to be stored in the abdominal cavity, that fat begins releasing inflammatory compounds and free fatty acids directly into the portal circulation that feeds the liver. This accelerates the very liver dysfunction described above. The fat is both a consequence of the cascade and an active driver of its continuation — a self-reinforcing loop that becomes harder to interrupt the longer it runs.
How metabolic syndrome forms — not as five separate problems but one interconnected collapse
Metabolic syndrome — defined as the co-occurrence of abdominal obesity, insulin resistance, high blood pressure, and dyslipidaemia — has insulin resistance at its mechanistic centre. Doctors often treat each component separately: a pill for blood pressure here, a statin for lipids there. But the cluster exists because the components share an upstream cause. Addressing the blood pressure without addressing the insulin resistance is the equivalent of replacing a fuse while the wiring is still on fire. The individual numbers may improve. The underlying process continues.
Why Standard Blood Tests Miss This Entirely
The normal glucose illusion — what the pancreas is doing behind the scenes
Here is the fundamental problem with relying on fasting glucose alone: it measures the outcome of insulin’s work, not the effort required to produce that outcome. A glucose reading of 5.0 mmol/L looks the same whether your pancreas needed to produce 5 units of insulin to achieve it or 25 units. The number that reveals the difference — fasting insulin — simply isn’t on the standard order form. In insulin resistance, the normal fasting coordination between insulin and counter-regulatory hormones like glucagon breaks down, disrupting the body’s ability to switch cleanly between its fed and fasted fuel states. But unless someone orders a fasting insulin test, this disruption leaves no fingerprint on a standard panel.
HOMA-IR explained: combining insulin and glucose for a real sensitivity score
The solution isn’t complicated. It’s a calculation called HOMA-IR (the Homeostatic Model Assessment of Insulin Resistance) — a formula that combines your fasting insulin and fasting glucose into a single number that reflects how hard your body is working to maintain glucose control. A HOMA-IR above 2.0 is widely used as an indicator of meaningful insulin resistance. Above 2.5, the concern becomes more significant. Above 3.0, it reflects a metabolic state that warrants active clinical attention. The calculation requires two numbers that can both be obtained from a single fasting blood draw. Its routine absence from standard panels is not a scientific justification — it’s a systems and prioritisation gap.
What to Test, What to Calculate, and What to Ask Your Doctor
The minimum metabolic testing panel worth requesting
- Fasting insulin (μIU/mL) — the test most likely to be missing from your current results
- Fasting glucose (mmol/L) — almost certainly already on your panel
- HOMA-IR calculation — derived from the two above using a free online calculator
- Fasting triglycerides — a lipid marker that reflects liver fat output and insulin status
- HDL cholesterol — falls as triglycerides rise in insulin-resistant states
- Waist circumference — the most accessible proxy for visceral fat
- Blood pressure — rises in parallel with insulin resistance for the reasons described above
- HbA1c — valuable as a complement to fasting insulin, not as a replacement for it
How to interpret your fasting insulin result and what numbers should concern you
A fasting insulin result below 5 μIU/mL is generally considered optimal. Between 5 and 10 μIU/mL sits in a range where context matters — your HOMA-IR calculation, your triglycerides, your waist circumference, and your family history all affect what that number means for you specifically. Above 10 μIU/mL in a fasted state is a meaningful signal regardless of what your glucose looks like. It tells you the bouncers are working hard. The club is crowded. The cascade described in this article is already under way to some degree. The question is how far along it is — and that’s a question worth answering now, not after your glucose eventually rises to confirm what the insulin was already telling you years earlier.
The conversation to have at your next appointment
You don’t need to arrive with a diagnosis. You need to arrive with a question. The most productive framing is not “I think I have insulin resistance” — it’s “I’d like to add fasting insulin to my next blood draw so we can calculate my HOMA-IR. My glucose is fine but I want to understand whether my insulin is compensating.” Most clinicians, when the question is put that way, will either agree immediately or explain a specific clinical reason why your situation is different. Either response is useful. What you want to avoid is leaving without knowing whether this upstream marker was measured — because if it wasn’t, the reassurance your results seem to offer is incomplete.
Pull your last blood test results now. Check whether fasting insulin appears anywhere on the page. If it doesn’t, that’s not a gap in your health — it’s a gap in your data. At your next blood test or GP visit, ask specifically for a fasting insulin result alongside your fasting glucose. Once you have both numbers, calculate your HOMA-IR score using a free online calculator (search ‘HOMA-IR calculator’ — input fasting insulin in μIU/mL and fasting glucose in mmol/L). If your HOMA-IR result comes back above 2.0, bring that number to your doctor and ask whether a full metabolic panel including triglycerides, HDL, blood pressure, and waist circumference is warranted — because that single number is your earliest upstream signal that the cascade described in this article may already be in motion.
